HK1045816A1 - Keratinocyte growth factor-2 formulations - Google Patents

Keratinocyte growth factor-2 formulations

Info

Publication number
HK1045816A1
HK1045816A1 HK02107430.1A HK02107430A HK1045816A1 HK 1045816 A1 HK1045816 A1 HK 1045816A1 HK 02107430 A HK02107430 A HK 02107430A HK 1045816 A1 HK1045816 A1 HK 1045816A1
Authority
HK
Hong Kong
Prior art keywords
formulations
growth factor
keratinocyte growth
keratinocyte
factor
Prior art date
Application number
HK02107430.1A
Other languages
Chinese (zh)
Inventor
L Gentz Reiner
Chopra Arvind
Kaushal Parveen
Spitznagel Thomas
Unsworth Edward
Khan Fazal
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of HK1045816A1 publication Critical patent/HK1045816A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK02107430.1A 1999-06-02 2002-10-11 Keratinocyte growth factor-2 formulations HK1045816A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13744899P 1999-06-02 1999-06-02
US16091399P 1999-10-22 1999-10-22
PCT/US2000/015186 WO2000072872A1 (en) 1999-06-02 2000-06-02 Keratinocyte growth factor-2 formulations

Publications (1)

Publication Number Publication Date
HK1045816A1 true HK1045816A1 (en) 2002-12-13

Family

ID=26835257

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02107430.1A HK1045816A1 (en) 1999-06-02 2002-10-11 Keratinocyte growth factor-2 formulations

Country Status (9)

Country Link
EP (1) EP1196187A4 (en)
JP (1) JP2003500456A (en)
KR (1) KR20020010920A (en)
CN (1) CN1359299A (en)
AU (1) AU5593200A (en)
CA (1) CA2375829A1 (en)
HK (1) HK1045816A1 (en)
MX (1) MXPA01012387A (en)
WO (1) WO2000072872A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077692A (en) 1995-02-14 2000-06-20 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US7232667B2 (en) 1995-02-14 2007-06-19 Human Genome Sciences, Inc. Keratinocyte growth factor-2 polynucleotides
US6693077B1 (en) 1995-02-14 2004-02-17 Human Genome Sciences, Inc. Keratinocyte growth factor-2
NZ505324A (en) 1997-12-22 2002-11-26 Human Genome Sciences Inc Liquid and lyophilised KGF-2 polypeptide formulations used to accelerate soft tissue growth or regeneration
US6869927B1 (en) 1997-12-22 2005-03-22 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
US6599879B1 (en) 1998-02-13 2003-07-29 Human Genome Sciences, Inc. Therapeutic uses of keratinocyte growth factor-2
US6835536B2 (en) 2001-08-21 2004-12-28 Micrologix Biotech Inc. Antimicrobial cationic peptides and formulations thereof
CA2542946A1 (en) 2003-10-28 2005-05-12 Medtronic, Inc. Methods of preparing crosslinked materials and bioprosthetic devices
AU2004288854B2 (en) * 2003-11-10 2009-10-01 Arriva-Pharmaceuticals, Inc. Dry recombinant human alpha 1-antitrypsin formulation
JP5201992B2 (en) * 2004-12-15 2013-06-05 バイオビトラム・アクテイエボラーグ（パブリツク） Keratinocyte growth factor therapeutic formulation
MY142987A (en) * 2005-06-08 2011-02-14 Hayashibara Biochem Lab Solution for tissue adhesion prevention and method for tissue adhesion prevention
CN100434117C (en) * 2006-06-06 2008-11-19 武汉大学 Suppository for treating chronic cervicitis
CN101578103B (en) * 2006-06-29 2013-09-25 林科杰诺米克斯株式会社 Agent for injection purposes comprising antibiotic, and solution for injection comprising the agent
JP2011507816A (en) * 2007-12-21 2011-03-10 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム Malaria vaccine
CN101642576B (en) * 2008-08-05 2011-08-17 温州医学院 Polyethylene glycol-modified product of KGF-2 and preparation method thereof
CN101537172B (en) * 2008-08-14 2010-06-30 温州医学院 Recombinant human keratinocyte growth factor-2 containing eye drops and method for preparing same
WO2011011808A1 (en) * 2009-07-30 2011-02-03 Roman Buga A cosmetic composition comprising sodium chloride in combination with one or more of protein, collagen, gelatin or amino acid
CN102727890A (en) * 2012-07-05 2012-10-17 吉林农业大学 Application of anti-recombinant human keratinocyte growth factor-2 antibody
US20180028627A1 (en) * 2015-02-26 2018-02-01 Bioventures, Llc Treatment vaccine for prostate cancer
CN106377760A (en) * 2016-10-26 2017-02-08 李天学 Application of preparation containing KGF-2 (keratinocyte growth factor-2) to relieving of diabetic ulcer
CN108338967B (en) * 2017-09-15 2020-11-20 浙江唯美生物科技有限公司 Collagen sustained-release hydrogel containing fibroblast growth factor 10
CN112512504A (en) * 2018-06-22 2021-03-16 温州医科大学 Hydrogel, pharmaceutical composition containing hydrogel and application of pharmaceutical composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06500802A (en) * 1991-06-14 1994-01-27 アムジエン・インコーポレーテツド Protein drug delivery using collagen film
US5965530A (en) * 1993-03-26 1999-10-12 Amgen Inc. Therapeutic uses of keratinocyte growth factor
EP0619115A1 (en) * 1993-04-01 1994-10-12 Amgen Inc. Container comprising a metered dose valve and microparticles of a drug for topical treatment of skin disorders
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
KR20000029986A (en) * 1996-08-13 2000-05-25 벤슨 로버트 에이치. Keratinocyte growth factor-2(kgf-2 or fibroblast growth factor-12, fgf-12)
DK0935652T3 (en) * 1996-10-15 2004-07-26 Amgen Inc Keratinocyte Growth Factor-2 Products
ES2297286T3 (en) * 1996-10-15 2008-05-01 Amgen Inc. USE OF PROTEIC PRODUCTS OF THE QUERATINOCITOS-2 GROWTH FACTOR.
NZ505324A (en) * 1997-12-22 2002-11-26 Human Genome Sciences Inc Liquid and lyophilised KGF-2 polypeptide formulations used to accelerate soft tissue growth or regeneration

Also Published As

Publication number Publication date
MXPA01012387A (en) 2002-08-23
EP1196187A1 (en) 2002-04-17
CA2375829A1 (en) 2000-12-07
EP1196187A4 (en) 2003-02-05
AU5593200A (en) 2000-12-18
CN1359299A (en) 2002-07-17
JP2003500456A (en) 2003-01-07
KR20020010920A (en) 2002-02-06
WO2000072872A1 (en) 2000-12-07

Similar Documents

Publication Publication Date Title
HK1045816A1 (en) Keratinocyte growth factor-2 formulations
AU2002309473A1 (en) Keratinocyte growth factor-2
PL350796A1 (en) Compositions for promoting growth
HUP0102482A3 (en) Formulations for controlling human lice
DE69934298D1 (en) GROWTH FACTORS CONTAINING PROSTHESIS
GB9804013D0 (en) Formulations
GB9812103D0 (en) Surgical implant
IL147253A0 (en) Growth hormone formulations
IL132625A0 (en) Composition for inducing hair growth
EP1054900A4 (en) Therapeutic uses of keratinocyte growth factor-2
GB9924959D0 (en) Implant alignment
GB9815001D0 (en) Formulations
GB9815002D0 (en) Formulations
EP1373299A4 (en) Connective tissue growth factor-2
AU137973S (en) Implant
AU2003203859A1 (en) Keratinocyte growth factor-2 formulations
ZA987083B (en) Hair growth formulation
GB9922300D0 (en) Disinfectant composition
GB9916252D0 (en) Growth hormone formulation
AU1907500A (en) Compositions and methods for disinfecting fabric
GB9905907D0 (en) Sterilant composition
HU9900222V0 (en) Dental implantation structure
GB9823253D0 (en) Disinfectant formulation
GB9918902D0 (en) Growth hormone formulation
GB0014097D0 (en) Remedy for natural hair growth